Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data

Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data

Abstract Background The recommendation for postoperative chemotherapy in pancreatic ductal adenocarcinoma (PDAC) is based on prospective randomized trials. However, patients included in clinical trials do not often reflect the overall patient population treated in clinical practice. Materials and me...

Full description

Bibliographic Details
Main Authors: Sophia Chikhladze, Ann-Kathrin Lederer, Lampros Kousoulas, Marilena Reinmuth, Olivia Sick, Stefan Fichtner-Feigl, Uwe A. Wittel
Format: Article
Language:English
Published: BMC 2019-11-01
Series:World Journal of Surgical Oncology
Subjects:
PDAC
Chemotherapy
Outcome
Mortality
Survival
Pancreas surgery
Online Access:http://link.springer.com/article/10.1186/s12957-019-1732-3

Internet

http://link.springer.com/article/10.1186/s12957-019-1732-3

Similar Items